Ubs Group Ag Casi Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 08, 2023	SELL	$1.48 - $2.79 $2,465 - $4,648	-1,666 Reduced 53.93%	1,423 $2,000
Q3 2022 Nov 10, 2022	BUY	$2.36 - $4.69 $7,290 - $14,487	3,089 New	3,089 $8,000

Ticker CASI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,606,100
Market Cap $81.8M
Description
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patien...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.